LGND
Ligand Pharmaceuticals Incorporated
NASDAQ · Healthcare · Biotechnology · US
$287.57
−0.75%Forward multiples
Based on analyst estimates
- P/E forward
- 27.89x
- P/E 2026E
- 30.85x
- P/E 2027E
- 23.72x
- P/E 2028E
- 19.76x
- P/S forward
- 17.00x
Trailing multiples
Trailing twelve months
- P/E TTM
- 28.73x
- PEG TTM
- 9.58x
- Price / book
- 5.93x
- Price / sales
- 19.73x
- Price / cash flow
- 43.55x
Enterprise value
- Enterprise value
- $5.5B
- EV / sales
- 18.95x
- EV / EBITDA
- 20.12x
- EV / EBIT
- 54.56x
- Market cap
- $5.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026